A recent study has put the spotlight on an age-old anti-inflammatory drug, colchicine, and its possible role in treating patients hospitalised with Covid-19 symptoms. According to a paper published in ...
 |
| READ THE ORIGINAL POST AT www.thehindubusinessline.com |
